[Changes in plasma ACTH activity by oral administration of SU-4485].
D015065:17-Hydroxycorticosteroids / Q000097:blood* / Q000652:urine; D000293:Adolescent; D000324:Adrenocorticotropic Hormone / Q000097:blood*; D000328:Adult; D000783:Aneurysm / Q000097:blood; D000818:Animals; D002940:Circadian Rhythm; D004938:Esophageal Neoplasms / Q000097:blood; D005260:Female; D006801:Humans; D007415:Intestinal Obstruction / Q000097:blood; D008297:Male; D008797:Metyrapone / Q000494:pharmacology*; D008875:Middle Aged; D010307:Parotid Neoplasms / Q000097:blood; D010912:Pituitary-Adrenal Function Tests; D013274:Stomach Neoplasms / Q000097:blood; D013276:Stomach Ulcer / Q000097:blood
D015065:17-Hydroxycorticosteroids; D000324:Adrenocorticotropic Hormone; D008797:Metyrapone